Literature DB >> 10207821

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in patients with primary biliary cirrhosis.

P L Lakatos, G Firneisz, G Rákóczy, L Selmeci, F Szalay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10207821     DOI： 10.1016/s0168-8278(99)80211-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

2.  Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.

Authors:  Kosuke Kaji; Hitoshi Yoshiji; Yasuhide Ikenaka; Ryuichi Noguchi; Yosuke Aihara; Akitoshi Douhara; Kei Moriya; Hideto Kawaratani; Yusaku Shirai; Junichi Yoshii; Koji Yanase; Mitsuteru Kitade; Tadashi Namisaki; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2013-03-12       Impact factor: 7.527

3.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

4.  Sitagliptin Is More Effective Than Gliclazide in Preventing  Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease.

Authors:  Jing Ren; Xiaoyu Wang; Christine Yee; Mark D Gorrell; Susan V McLennan; Stephen M Twigg
Journal:  Molecules       Date:  2022-01-22       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.